Arisara Amrapala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arisara Amrapala has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Michael Maes
Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
7 shared publications - Marco Solmi
SCIENCES Lab, Department of Psychiatry, University of Ottawa, Ottawa, ON K1N 6N5, Canada
3 shared publications - Solaphat Hemrungrojn
Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3 shared publications - Chavit Tunvirachaisakul
Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
2 shared publications - Gallayaporn Nantachai
Chulalongkorn University
2 shared publications - Michel Sabé
Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland
2 shared publications
Latest Publications
- Open Access
Circulating Apolipoprotein Profiles and Their Associations with Mild Cognitive and Behavioral Impairment in Older Adults: A Cross-Sectional Study
Background: Mild cognitive impairment (MCI) and mild behavioral impairment (MBI) are overlapping prodromal states associated with dementia risk. Circulating apolipoproteins (Apos) may be linked to cognitive and behavioral changes, but their relationships remain unclear. Objective: Examine plasma concentrations of multiple Apos in prodromal dementia. Methods: This cross-sectional study included 148 Thai participants aged 60-75 years: 56 cognitively normal controls, 47 with MCI without MBI, and 45 with MBI with or without MCI. We measured ApoA1, ApoA2, ApoB, ApoC1, ApoC3, ApoD, ApoE, ApoH, and ApoJ, five lipids, and APOE genotype, and computed an atherogenic Apo composite (ApoB-ApoC1-ApoC3). Primary analyses used multivariable linear regression of quantitative cognitive and behavioral outcomes. Group comparisons were secondary and served to contextualize the dimensional regression findings. Results: Across Montreal Cognitive Assessment (MoCA) models, 20.7-28.2% of variance was explained by combinations of ApoH, ApoC3, APOE ε4 carrier status, age, and male sex (inverse associations), and free cholesterol and education (positive associations). The atherogenic composite was inversely associated with MoCA total, memory index, and delayed recall scores, and with Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) verbal fluency and word list recall. No significant predictors emerged for Neuropsychiatric Inventory (NPI) scores or NPI caregiver distress. All nine Apos differed significantly between groups, with levels highest in MCI, intermediate in MBI, and lowest in controls. Conclusions: Circulating Apo profiles differed across controls, MCI, and MBI groups and were more consistently associated with cognitive than behavioral outcomes. ApoH and the atherogenic Apo composite warrant further investigation as candidate biomarkers of early cognitive dysfunction.
Open AccessCirculating Apolipoprotein Profiles and Their Associations with Mild Cognitive and Behavioral Impairment in Older Adults: A Cross-Sectional Study
Background: Mild cognitive impairment (MCI) and mild behavioral impairment (MBI) are overlapping prodromal states associated with dementia risk. Circulating apolipoproteins (Apos) may be linked to cognitive and behavioral changes, but their relationships remain unclear. Objective: Examine plasma concentrations of multiple Apos in prodromal dementia. Methods: This cross-sectional study included 148 Thai participants aged 60-75 years: 56 cognitively normal controls, 47 with MCI without MBI, and 45 with MBI with or without MCI. We measured ApoA1, ApoA2, ApoB, ApoC1, ApoC3, ApoD, ApoE, ApoH, and ApoJ, five lipids, and APOE genotype, and computed an atherogenic Apo composite (ApoB-ApoC1-ApoC3). Primary analyses used multivariable linear regression of quantitative cognitive and behavioral outcomes. Group comparisons were secondary and served to contextualize the dimensional regression findings. Results: Across Montreal Cognitive Assessment (MoCA) models, 20.7-28.2% of variance was explained by combinations of ApoH, ApoC3, APOE ε4 carrier status, age, and male sex (inverse associations), and free cholesterol and education (positive associations). The atherogenic composite was inversely associated with MoCA total, memory index, and delayed recall scores, and with Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) verbal fluency and word list recall. No significant predictors emerged for Neuropsychiatric Inventory (NPI) scores or NPI caregiver distress. All nine Apos differed significantly between groups, with levels highest in MCI, intermediate in MBI, and lowest in controls. Conclusions: Circulating Apo profiles differed across controls, MCI, and MBI groups and were more consistently associated with cognitive than behavioral outcomes. ApoH and the atherogenic Apo composite warrant further investigation as candidate biomarkers of early cognitive dysfunction.
- Open Access
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S3) , e096008
NPS in MCI: A scientometric analysis
Background: A scientometric study of the existing research on behavioral and psychological symptoms of dementia (BPSD) in mild cognitive impairment (MCI) was conducted to obtain key trends, influential networks, and major contributors in the field. Method: Relevant literature was retrieved from the Web of Science database, with full‐text and citation records extracted for analysis. Author and journal information was retrieved using the Bibliometrix R package; CiteSpace was used to compute the co‐citation analysis, co‐occurrence analysis, and collaboration networks; and VOS‐viewer was employed to visualize network maps of the most‐cited journals and co‐occurring author keywords network. Result: Our search found 12,369 studies published between 1980 and 2022 that satisfied the inclusion criteria. Co‐citation analysis unveiled 51 highly credible clusters (significant modularity score of 0.856 and silhouette score of 0.932), with the largest cluster encompassing ‘cognitive disorders’. Five general research domains were derived from the network: symptoms, diagnosis, brain substrates, biochemical pathways, and interventions. Data from recent years highlighted ‘depression’ as the most cited keyword, while current research focused on gut microbiota, e‐health, COVID‐19, cognition, and delirium. The USA and UK had the highest influence and citations, and the PRC exhibited notable growth. Conclusion: This scientometric approach provides a comprehensive overview of the research evolution, emerging trends, and key focus areas in BPSD in MCI. These findings offer valuable insights for researchers and clinicians, aiding in evidence‐based decision‐making and enhancing the quality of future research in this domain.
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S3) , e096008
Open AccessNPS in MCI: A scientometric analysis
Background: A scientometric study of the existing research on behavioral and psychological symptoms of dementia (BPSD) in mild cognitive impairment (MCI) was conducted to obtain key trends, influential networks, and major contributors in the field. Method: Relevant literature was retrieved from the Web of Science database, with full‐text and citation records extracted for analysis. Author and journal information was retrieved using the Bibliometrix R package; CiteSpace was used to compute the co‐citation analysis, co‐occurrence analysis, and collaboration networks; and VOS‐viewer was employed to visualize network maps of the most‐cited journals and co‐occurring author keywords network. Result: Our search found 12,369 studies published between 1980 and 2022 that satisfied the inclusion criteria. Co‐citation analysis unveiled 51 highly credible clusters (significant modularity score of 0.856 and silhouette score of 0.932), with the largest cluster encompassing ‘cognitive disorders’. Five general research domains were derived from the network: symptoms, diagnosis, brain substrates, biochemical pathways, and interventions. Data from recent years highlighted ‘depression’ as the most cited keyword, while current research focused on gut microbiota, e‐health, COVID‐19, cognition, and delirium. The USA and UK had the highest influence and citations, and the PRC exhibited notable growth. Conclusion: This scientometric approach provides a comprehensive overview of the research evolution, emerging trends, and key focus areas in BPSD in MCI. These findings offer valuable insights for researchers and clinicians, aiding in evidence‐based decision‐making and enhancing the quality of future research in this domain.
- Open Access
Disorders in lipid metabolism, oxidative stress, and antioxidants in patients with amnestic mild cognitive impairment without major depression
Background: Amnestic mild cognitive impairment (aMCI) is characterized by changes in lipids and oxidative stress (OS). It is crucial to exclude patients with major depression (MDD) to accurately evaluate these biomarkers in aMCI. Aims: To examine lipid and oxidative stress biomarkers associated with aMCI versus normal controls. Methods: We performed a case-control analysis involving 61 individuals with aMCI (without MDD) and 60 healthy controls. We assessed the severity of aMCI, distress symptoms of old age, and lipid/OS biomarkers. Results: The levels of serum -SH groups were significantly higher in individuals with aMCI, while the levels of malondialdehyde (MDA) were significantly lower in the same group. Serum advanced oxidation protein products, glutathione, and folic acid did not show any notable variations. In individuals with aMCI, we observed an elevated apolipoprotein B (ApoB)/ApoA ratio, as well as decreased levels of high-density lipoprotein cholesterol (HDL), ApoA, and a reverse cholesterol transport (RCT) index. The simultaneous presence of aMCI and subclinical depressive symptoms is marked by elevated levels of triglycerides and ApoB, as well as decreased levels of ApoA and HDL. A significant portion of the variability (24.9%) in a quantitative MCI severity score can be attributed to -SH groups, age (positively), MDA and education (inversely). Discussion: The alterations in MDA and -SH levels in aMCI may potentially disrupt redox signaling, which can affect cell signaling and homeostatic setpoints. The interaction between aMCI and subclinical depressive symptoms can lead to increased atherogenicity and reduced antiatherogenic protection.
Open AccessDisorders in lipid metabolism, oxidative stress, and antioxidants in patients with amnestic mild cognitive impairment without major depression
Background: Amnestic mild cognitive impairment (aMCI) is characterized by changes in lipids and oxidative stress (OS). It is crucial to exclude patients with major depression (MDD) to accurately evaluate these biomarkers in aMCI. Aims: To examine lipid and oxidative stress biomarkers associated with aMCI versus normal controls. Methods: We performed a case-control analysis involving 61 individuals with aMCI (without MDD) and 60 healthy controls. We assessed the severity of aMCI, distress symptoms of old age, and lipid/OS biomarkers. Results: The levels of serum -SH groups were significantly higher in individuals with aMCI, while the levels of malondialdehyde (MDA) were significantly lower in the same group. Serum advanced oxidation protein products, glutathione, and folic acid did not show any notable variations. In individuals with aMCI, we observed an elevated apolipoprotein B (ApoB)/ApoA ratio, as well as decreased levels of high-density lipoprotein cholesterol (HDL), ApoA, and a reverse cholesterol transport (RCT) index. The simultaneous presence of aMCI and subclinical depressive symptoms is marked by elevated levels of triglycerides and ApoB, as well as decreased levels of ApoA and HDL. A significant portion of the variability (24.9%) in a quantitative MCI severity score can be attributed to -SH groups, age (positively), MDA and education (inversely). Discussion: The alterations in MDA and -SH levels in aMCI may potentially disrupt redox signaling, which can affect cell signaling and homeostatic setpoints. The interaction between aMCI and subclinical depressive symptoms can lead to increased atherogenicity and reduced antiatherogenic protection.
- 20 November 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 92, 102129
Neuropsychiatric disturbances in mild cognitive impairment: A scientometric analysis
- 20 November 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 92, 102129
Neuropsychiatric disturbances in mild cognitive impairment: A scientometric analysis
- Open Access
Neuropsychiatric Disturbances in Mild Cognitive Impairment: A Scientometric Analysis
Behavioral and psychological symptoms of dementia (BPSD) have been extensively studied in dementia than its prodromal stage, known as mild cognitive impairment (MCI). A scientometric study on BPSD in MCI would be valuable in synthesizing the existing body of research and provide insights into the trends, networks, and influencers within this area. We searched for related literature in the Web of Science database and extracted complete text and citation records of each publication. The primary objective was to map the research evolution of BPSD in MCI and highlight dominant research themes. The secondary objective was to identify research network characteristics (authors, journals, countries, and institutions) and abundances. A total of 12,369 studies published between 1980 to 2022 were included in the analysis. We found 51 distinct clusters from the co-cited reference network that were highly credible with significant modularity (Q = 0.856) and silhouette scores (S = 0.932). Five major research domains were identified: symptoms, diagnosis, brain substrates, biochemical pathways, and interventions. Within recent years, the research focus in this area is on gut microbiota, e-health, COVID-19, cognition, and delirium. Collectively, findings from this scientometric analysis can help clarify the scope and direction of future research and clinical practices.
Open AccessNeuropsychiatric Disturbances in Mild Cognitive Impairment: A Scientometric Analysis
Behavioral and psychological symptoms of dementia (BPSD) have been extensively studied in dementia than its prodromal stage, known as mild cognitive impairment (MCI). A scientometric study on BPSD in MCI would be valuable in synthesizing the existing body of research and provide insights into the trends, networks, and influencers within this area. We searched for related literature in the Web of Science database and extracted complete text and citation records of each publication. The primary objective was to map the research evolution of BPSD in MCI and highlight dominant research themes. The secondary objective was to identify research network characteristics (authors, journals, countries, and institutions) and abundances. A total of 12,369 studies published between 1980 to 2022 were included in the analysis. We found 51 distinct clusters from the co-cited reference network that were highly credible with significant modularity (Q = 0.856) and silhouette scores (S = 0.932). Five major research domains were identified: symptoms, diagnosis, brain substrates, biochemical pathways, and interventions. Within recent years, the research focus in this area is on gut microbiota, e-health, COVID-19, cognition, and delirium. Collectively, findings from this scientometric analysis can help clarify the scope and direction of future research and clinical practices.
- Open Access
Cognitive features of amnestic Mild Cognitive Impairment using specific Cambridge Neuropsychological Test Automated Battery test scores
Background: In older adults with amnestic Mild Cognitive Impairment (aMCI), the Cambridge Neuropsychological Test Automated Battery (CANTAB) probes indicated cognitive impairments most frequently in memory. Objectives: This study aimed to investigate a) the cognitive features of aMCI using memory CANTAB tests and b) whether the clinical diagnosis of aMCI can be externally validated by these CANTAB measurements. Methods: We tested CANTAB tests that are specific to aMCI on 65 healthy controls and 66 people with aMCI who were diagnosed using Petersen’s criteria. These tests were spatial working memory (SWM), visual pattern recognition memory (PRM), delayed matching to sample (DSM), spatial span (SSP), and rapid visual information processing (RVP). Results: The key aMCI features are impairments in PRM and DSM, whilst deficits in SSP and RVP are other, albeit somewhat less important features of aMCI. Nevertheless, neural network analyses including 10 CANTAB domains specific for MCI showed that only 70.8 percent of all subjects were properly identified with a sensitivity of 77.3%, specificity of 65.4% and an area under the ROC curve of 0.760. K-means cluster analysis using the same specific CANTAB test scores discovered 2 clusters with an adequate silhouette measure of cohesion and separation including a cluster with 36 subjects showing impairments in most neurocognitive tests. Conclusion: Deficits in spatial working, pattern recognition and visuospatial working memory as well as rapid visual information processing are key features of aMCI. Nevertheless, the clinical diagnosis of aMCI according to Petersen’s criteria is overinclusive because too many healthy controls are allocated to this group.
Open AccessCognitive features of amnestic Mild Cognitive Impairment using specific Cambridge Neuropsychological Test Automated Battery test scores
Background: In older adults with amnestic Mild Cognitive Impairment (aMCI), the Cambridge Neuropsychological Test Automated Battery (CANTAB) probes indicated cognitive impairments most frequently in memory. Objectives: This study aimed to investigate a) the cognitive features of aMCI using memory CANTAB tests and b) whether the clinical diagnosis of aMCI can be externally validated by these CANTAB measurements. Methods: We tested CANTAB tests that are specific to aMCI on 65 healthy controls and 66 people with aMCI who were diagnosed using Petersen’s criteria. These tests were spatial working memory (SWM), visual pattern recognition memory (PRM), delayed matching to sample (DSM), spatial span (SSP), and rapid visual information processing (RVP). Results: The key aMCI features are impairments in PRM and DSM, whilst deficits in SSP and RVP are other, albeit somewhat less important features of aMCI. Nevertheless, neural network analyses including 10 CANTAB domains specific for MCI showed that only 70.8 percent of all subjects were properly identified with a sensitivity of 77.3%, specificity of 65.4% and an area under the ROC curve of 0.760. K-means cluster analysis using the same specific CANTAB test scores discovered 2 clusters with an adequate silhouette measure of cohesion and separation including a cluster with 36 subjects showing impairments in most neurocognitive tests. Conclusion: Deficits in spatial working, pattern recognition and visuospatial working memory as well as rapid visual information processing are key features of aMCI. Nevertheless, the clinical diagnosis of aMCI according to Petersen’s criteria is overinclusive because too many healthy controls are allocated to this group.
- Open Access
- 12 June 2022
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (1) , 16-27
Construction of a short version of the Montreal Cognitive Assessment (MoCA) rating scale for the Thai population using Partial Least Squares analysis
The Montreal Cognitive Assessment (MoCA) rating scale is frequently used to assess cognitive impairments in amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD).The aims of this s...
- 12 June 2022
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (1) , 16-27
Open AccessConstruction of a short version of the Montreal Cognitive Assessment (MoCA) rating scale for the Thai population using Partial Least Squares analysis
The Montreal Cognitive Assessment (MoCA) rating scale is frequently used to assess cognitive impairments in amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD).The aims of this s...
- Open Access
Construction of a short version of the Montreal Cognitive Assessment (MoCA) rating scale using Partial Least Squares analysis
Background: The Montreal Cognitive Assessment (MoCA) rating scale is frequently used to assess cognitive impairments in amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD). Objectives: The aims of this study are to a) evaluate the construct validity of the MoCA and its subdomains or whether the MoCA can be improved by feature reduction, and b) develop a short version of the MoCA (MoCA-Brief). Methods: We recruited 181 participants, divided into 60 healthy controls, 61 aMCI, and 60 AD patients. Results: The construct reliability of the original MoCA was not optimal and could be improved by deleting one subdomain (Naming) and five items, namely Clock Circle, Lion, Digit Forward, Repeat 2 nd Sentence, and Place, which showed inadequate loadings on the extracted latent vectors. To construct the MoCA-Brief, the reduced model underwent further reduction and feature selection based on model quality data of the outer models. We produced a MoCA-Brief rating scale comprising five items, namely Clock Time, Subtract 7, Fluency, Month, and Year. The first latent vector extracted from these five indicators showed adequate construct validity with an Average Variance Extracted of 0.599, composite reliability of 0.822, Cronbach’s alpha of 0.832 and rho_A of 0.833. The MoCA-Brief factor score showed a strong correlation with the total MoCA score (r=0.98, p<0.001) and shows adequate concurrent, test-retest, and inter-rater validity. Conclusion: The construct validity of the MoCA may be improved by deleting five items. The new MoCA-Brief rating scale deserves validation in independent samples and especially in other countries.
Open AccessConstruction of a short version of the Montreal Cognitive Assessment (MoCA) rating scale using Partial Least Squares analysis
Background: The Montreal Cognitive Assessment (MoCA) rating scale is frequently used to assess cognitive impairments in amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD). Objectives: The aims of this study are to a) evaluate the construct validity of the MoCA and its subdomains or whether the MoCA can be improved by feature reduction, and b) develop a short version of the MoCA (MoCA-Brief). Methods: We recruited 181 participants, divided into 60 healthy controls, 61 aMCI, and 60 AD patients. Results: The construct reliability of the original MoCA was not optimal and could be improved by deleting one subdomain (Naming) and five items, namely Clock Circle, Lion, Digit Forward, Repeat 2 nd Sentence, and Place, which showed inadequate loadings on the extracted latent vectors. To construct the MoCA-Brief, the reduced model underwent further reduction and feature selection based on model quality data of the outer models. We produced a MoCA-Brief rating scale comprising five items, namely Clock Time, Subtract 7, Fluency, Month, and Year. The first latent vector extracted from these five indicators showed adequate construct validity with an Average Variance Extracted of 0.599, composite reliability of 0.822, Cronbach’s alpha of 0.832 and rho_A of 0.833. The MoCA-Brief factor score showed a strong correlation with the total MoCA score (r=0.98, p<0.001) and shows adequate concurrent, test-retest, and inter-rater validity. Conclusion: The construct validity of the MoCA may be improved by deleting five items. The new MoCA-Brief rating scale deserves validation in independent samples and especially in other countries.